What to Know About Syfovre and Izervay for Geographic Atrophy
By Reena Mukamal Feb. 18, 2024 for the American Academy of Ophthalmology Two new drugs – Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) – were approved in 2023 for geographic atrophy, a potentially debilitating type of dry age-related macular degeneration (AMD). The disease affects about one million Americans and can lead to significant vision loss. For …